Cargando…
Vorinostat ameliorates IL‐1α‐induced reduction of type II collagen by inhibiting the expression of ELF3 in chondrocytes
Osteoarthritis (OA) is a common joint disease that ultimately causes physical disability and imposes an economic burden on society. Cartilage destruction plays a key role in the development of OA. Vorinostat is an oral histone deacetylase (HDAC) inhibitor and has been used for the treatment of T‐cel...
Autores principales: | Miao, Xudong, Wu, Yongping, Wang, Ping, Zhang, Qiang, Zhou, Chenhe, Yu, Xinning, Cao, Le |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8519056/ https://www.ncbi.nlm.nih.gov/pubmed/34250664 http://dx.doi.org/10.1002/jbt.22844 |
Ejemplares similares
-
Effect of Amniotic Membrane/Collagen-Based Scaffolds on the Chondrogenic Differentiation of Adipose-Derived Stem Cells and Cartilage Repair
por: Cao, Le, et al.
Publicado: (2021) -
Vorinostat—An Overview
por: Bubna, Aditya Kumar
Publicado: (2015) -
Phospholipase D1 is upregulated by vorinostat and confers resistance to vorinostat in glioblastoma
por: Kang, Dong Woo, et al.
Publicado: (2020) -
Elf-1 Contributes to the Function of the Complex Interleukin (IL)-2–responsive Enhancer in the Mouse IL-2 Receptor α Gene
por: Serdobova, Irina, et al.
Publicado: (1997) -
Vorinostat in solid and hematologic malignancies
por: Siegel, David, et al.
Publicado: (2009)